Marksans Pharma Ltd - MARKSANS PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE750C01026
₹ 160.55 (3.02%) icon16 Apr, 2024, 9:24:54 AM

Marksans Pharma Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/16/2024 9:24:54 AM

    ₹ 160.55 4.70 3.02
  • Open
  • ₹ 159
  • Prev. Close
  • ₹ 155.85
  • Turnover(Lac.)
  • ₹ 972
  • Day's High
  • ₹ 161.8
  • Day's Low
  • ₹ 158.75
  • 52 Week's High
  • ₹ 179.3
  • 52 Week's Low
  • ₹ 70.55
  • Book Value
  • ₹ 26.75
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 7,275.54
  • P/E
  • 59.5
  • EPS
  • 2.62
  • Divi. Yield
  • 0.32

Marksans Pharma Ltd Corporate Actions

17 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 Jan , 2024

12:00 AM

27 Oct , 2023

12:00 AM

27 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Aug , 2023

12:00 AM

AGM

Announcement date: 02 Aug , 2023

View Details

02 Aug , 2023

12:00 AM

02 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 May , 2023

12:00 AM

Dividend

Dividend amount: 0.5
Announcement date: 30 May , 2023

View Details

17 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

No Record Found


Marksans Pharma Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Marksans Pharma Ltd SHAREHOLDING SNAPSHOT
16 April , 2024 | 09:43 AM

PROMOTER - TOTAL43.85%

Indian: 43.85%

Foreign: 0%

NON-PROMOTER - TOTAL 56.15%

Institutions: 20.32%

Non-Institutions: 35.83%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Marksans Pharma Ltd FINANCIALS

Marksans Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Marksans Pharma Ltd

  • Mark Saldanha
  • Chairman & Managing Director
  • Harshavardhan Panigrahi
  • Company Sec. & Compli. Officer
  • Seetharama Raju Buddharaju
  • Non-Exec. & Independent Dir.
  • Sandra Saldanha
  • Whole-time Director
  • Digant Mahesh Parikh
  • Non-Exec. & Independent Dir.
  • Varddhman Vikramaditya Jain
  • Whole-time Director
  • Abhinna Sundar Mohanty
  • Non-Exec. & Independent Dir.
  • Sunny Sharma
  • Director
  • Shailaja Vardhan
  • Independent Director

Summary

Marksans Pharma Limited is a public limited company incorporated in the year April 16th, 1982. The Company is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation. The Companys research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai.The Company on 30th March 2015, issued and allotted 240,06,494 equity shares of Rs1/- each to qualified institutional buyers under QIP for cash at Rs54.67 (including premium) per Equity Share. In accordance to terms of issue, the Directors in their meeting held on 7th February, 2015 decided to redeem entire 13,50,000 7% Redeemable Cumulative Preference Shares of face value Rs100/- per share at par out of profits in tranches before due date of redemption i.e 27th March, 2018. Accordingly, on 7th February 2015, the Directors redeemed 1,00,000 preference shares at par.The Company issued 50,000 Bonds of USD 1,000 each in principal value during the financial year 2015. As on date of report, the Company bought back and extinguished 49,939 Bonds. Of which, only 61 Bonds of USD 1,000 each in principal value (out of total 50,000 Bonds issued) remained outstanding as the same are not traceable During the year 2017, the Company redeemed 1,50,000 preference shares of Rs100/-each at par. Accordingly, issued, subscribed and paid-up preference share capital reduced from 12,50,000 preference shares of Rs100/- each to 11,00,000 preference shares of Rs100/- each with... Read More


Reports by Marksans Pharma Ltd


Reports by Marksans Pharma Ltd

Company FAQ

No Record Found